Replies to post #178770 on Biotech Values

[DewDiligence]

WSJ on the CGRP approach to treating migraine:

http://online.wsj.com/news/articles/SB10000872396390444320704577567352444742524

This article went to press too soon to know about Teva’s deal with Labrys (#msg-102832891).